Cabotegravir is a long-acting antiretroviral medicine used as for HIV prevention in people vulnerable to infection. © Isabel Corthier
Blog |
05 October 2022

South Africa can and must demand better deals for drug clinical trials — lives depend on it

Photograph by Isabel Corthier

Clinical trials are a fundamental pillar of the research and development (R&D) process for any new drug or vaccine. South Africa’s involvement in several recent trials has been essential to international pharmaceutical companies’ global rollouts — but, argue Candice Sehoma and Lebohang Kobola, the government needs to stand firm and negotiate more shrewdly for access to these medicines.